SciELO - Scientific Electronic Library Online

 
vol.39 issue2 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Cirugía paraguaya

On-line version ISSN 2307-0420

Abstract

DA SILVA, Luis et al. UTILIDAD DE LA CPRE EN LA PANCREATITIS AGUDA BILIAR E ICTERICIA: UTILITY IN ERCP ACUTE BILIARY PANCREATITIS AMD JAUNDICE. Rev. Cir. Parag. [online]. 2015, vol.39, n.2, pp.20-23. ISSN 2307-0420.  https://doi.org/10.18004/sopaci.2015.diciembre.20-23.

ABSTRACT The use of endoscopic retrograde cholangiopancreatography- Pancreatography (ERCP) in Acute Pancreatitis, mainly in the home Billiards (PAB) has not been without controversy. There have been several prospective randomized studies comparing early unblocking biliopancreatic endoscopic versus conservative treatment. Which do not show a significant difference between the morbidity and mortality of acute pancreatitis and jaundice between the two groups. Other more recent studies show similar results (systematic and structured summaries Revisions). With respect to the decision to perform or not an ERCP, the American Society for Gastrointestinal Endoscopy (ASGE), published a guide in 2010, in which clinical predictors are used to assign three groups of risk of choledocholithiasis. The indication for ERCP in patients with acute pancreatitis and jaundice which do not cholangitis or high risk of choledocholithiasis, still deserves a better assessment of it as indicators of cholelithiasis factors are not always present and if they are, have false positives requiring us to take extra resources to avoid unnecessary ERCP, high cost in our midst and not without complications.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License